Your browser doesn't support javascript.
loading
Carfilzomib combined with ex vivo-expanded patient autologous natural killer cells for myeloma immunotherapy.
Chang, S K; Hou, J; Chen, G G; Yu, D D; Wu, H Q; Xie, Y S; Hu, L N; Gao, L; Xiao, W Q; Kong, Y Y; Tao, Y; Shi, J M.
Afiliación
  • Chang SK; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Hou J; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Chen GG; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Yu DD; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Wu HQ; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Xie YS; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Hu LN; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Gao L; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Xiao WQ; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Kong YY; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Tao Y; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Shi JM; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Neoplasma ; 65(5): 720-729, 2018 Sep 19.
Article en En | MEDLINE | ID: mdl-29940772

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Células Asesinas Naturales / Inmunoterapia / Mieloma Múltiple Límite: Humans Idioma: En Revista: Neoplasma Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Eslovaquia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Células Asesinas Naturales / Inmunoterapia / Mieloma Múltiple Límite: Humans Idioma: En Revista: Neoplasma Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Eslovaquia